These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17026800)

  • 1. Adjuvant therapy of renal cell carcinoma.
    Yap TA; Eisen TG
    Clin Genitourin Cancer; 2006 Sep; 5(2):120-30. PubMed ID: 17026800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy for renal cell carcinoma.
    Jacobsohn KM; Wood CG
    Semin Oncol; 2006 Oct; 33(5):576-82. PubMed ID: 17045086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant and adjuvant strategies in renal cell carcinoma: more questions than answers.
    Homicsko K; Berthold DR
    Anticancer Drugs; 2011 Jan; 22 Suppl 1():S4-8. PubMed ID: 21173604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma?
    Brookman-May S; May M; Gilfrich C; Wieland WF; Burger M
    Expert Rev Anticancer Ther; 2010 Jun; 10(6):813-23. PubMed ID: 20553207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of surgery and systemic therapy for renal cell carcinoma.
    Kenney PA; Wood CG
    Urol Clin North Am; 2012 May; 39(2):211-31, vii. PubMed ID: 22487764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EORTC-GU group expert opinion on metastatic renal cell cancer.
    de Reijke TM; Bellmunt J; van Poppel H; Marreaud S; Aapro M
    Eur J Cancer; 2009 Mar; 45(5):765-73. PubMed ID: 19157861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of therapy for advanced renal cell carcinoma.
    Basso M; Cassano A; Barone C
    Urol Oncol; 2010; 28(2):121-33. PubMed ID: 19576800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel immunotherapeutic strategies in development for renal cell carcinoma.
    Inman BA; Harrison MR; George DJ
    Eur Urol; 2013 May; 63(5):881-9. PubMed ID: 23084331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of adjuvant therapy in non-metastatic RCC.
    Bleumer I; de Mulder PH; Mulders PF
    Can J Urol; 2006 Apr; 13 Suppl 2():57-62. PubMed ID: 16672131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of metastatic renal cell carcinoma.
    Reeves DJ; Liu CY
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):11-25. PubMed ID: 19343348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome.
    Wood CG
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):697s-702s. PubMed ID: 17255296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma: current status and future prospects.
    Drucker BJ
    Cancer Treat Rev; 2005 Nov; 31(7):536-45. PubMed ID: 16236454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of renal cell carcinoma with interferons].
    Oya M
    Nihon Rinsho; 2006 Jul; 64(7):1281-5. PubMed ID: 16838645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care.
    Bex A; Gore M; Mulders P; Sternberg CN
    BJU Int; 2012 Nov; 110(9):1289-300. PubMed ID: 22624610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination systemic therapy for advanced renal cell carcinoma.
    Miller RE; Larkin JM
    Oncologist; 2009 Dec; 14(12):1218-24. PubMed ID: 19939892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine therapy in patients with renal cell carcinoma.
    Van Poppel H; Joniau S; Van Gool SW
    Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors.
    Chan HY; Grossman AB; Bukowski RM
    Adv Ther; 2010 Aug; 27(8):495-511. PubMed ID: 20623346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for metastatic renal cell carcinoma.
    Wirth MP
    Urol Clin North Am; 1993 May; 20(2):283-95. PubMed ID: 7684167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.